This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pfizer, Forget AstraZeneca -- Check Out These Biotechs: StockTwits

An email to Amarin's corporate press office requesting comment was not immediately returned.

StockTwits' users also suggested GlaxoSmithKline  (GSK). Like AstraZeneca, GlaxoSmithKline is based in the U.K. However, it is much more expensive, with a $132 billion market cap. That's not too far from Pfizer's valuation.

$PFE if they not take $AZN, they will look for another .... maybe $GSK? Or is that to much? ? Nobody (@JackKu) May. 19 at 06:49 AM

Some StockTwits users said Pfizer's cash would be better spent buying biotech companies with the potential for new blockbuster drugs, rather than focusing on a so-called "inversion transaction" to save on taxes. They said that Pfizer needs more innovative drugs in its pipeline than palbociclib, the breast cancer drug that Pfizer submitted to the FDA last week as part of a combo treatment for post-menopausal women suffering from certain types of breast cancer.

StockTwits users suggested Celgene  (CELG), which has a $58.94 billion market cap and is running more than 300 clinical trials, many for cancer drugs. They also mentioned Gilead Sciences  (GILD), the California-based biotech focused on treatments for HIV, with a $125 billion market cap.

@ctymkiw $PFE should just use their cash and purchase other biotech stocks like maybe a $BMRN $GILD $CELG maybe and forget about $AZN ? BiopharmaPro (@BiopharmaPro) May. 19 at 07:50 AM

Still other StockTwits users doubted Monday that Pfizer's bid for AstraZeneca is really over. They argued that there are additional synergies, besides the tax rate, that make AstraZeneca attractive. Pfizer could come back with an improved deal, despite its "final" language, or AstraZeneca's shareholders could revolt and force the board to reconsider.

$PFE will buy $AZN eventually, they want the tax breaks. Just a matter of when AZN will finally accept a bid ? Jared Cummans (@JaredCummans) May. 19 at 09:24 AM

 

At the time of publication the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,001.22 -38.27 -0.22%
S&P 500 1,988.40 -3.97 -0.20%
NASDAQ 4,538.5510 +6.4470 0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs